Europe Needle Free Injection Market Report Analysis, Research Studies | Antares Pharma, PharmaJet, Fierce Pharma, Medical International Technology

The Europe needle-free injection market was valued at USD 43.77 million in 2024 and is projected to grow to USD 71.20 million by 2031, with a CAGR of 6.4% during the forecast period (2024-2031).

Will the Europe Needle Free Injection market emerge as the sector's next great thing? To discover the answer, look at the Europe Needle Free Injection market analysis and projections. In-depth insight of the opportunities, difficulties, and trends now impacting the Machinery landscape is provided by this market research study, empowering industry participants to make informed decisions in a changing environment. Take advantage of the opportunity in the Europe Needle Free Injection market! (2031)

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/europe-needle-free-injection-market

Market Dynamics:

The growth of the Europe needle-free injection market is fueled by technological advancements, increasing regulatory approvals, a rising preference for self-administration of medications, heightened patient awareness, growing prevalence of chronic diseases, and higher patient healthcare expenditure.
The surge in chronic diseases across European countries is a significant driver of market growth.

The increasing prevalence of chronic conditions, such as cardiovascular disease and diabetes, along with advancements in technology, is propelling market expansion. For instance, cardiovascular disease (CVD) causes 3.9 million deaths annually in Europe, accounting for 45% of all deaths in the region. Respiratory diseases contribute to one in eight deaths in the EU, with 600,000 fatalities each year. Diabetes affects 58 million people in Europe, with an additional 36 million at risk, leading to 477,000 deaths annually and EUR 143 billion in direct healthcare costs. Chronic kidney disease (CKD) affects approximately 10% of the population, with 70 million Europeans experiencing some degree of kidney function loss, and one in three Europeans at increased risk of developing CKD.

Segment Covered in the Europe Needle Free Injection Market:

By Type: Liquid-based, Projectile, Powder-based

By Application: Vaccine Delivery, Insulin Delivery, Pain Management, Others

By End-User: Hospital, Clinics, Home Care settings, Others

Major Key players involved in Europe Medical Refrigerators Market

· Antares Pharma
· PharmaJet
· Fierce Pharma
· Medical International Technology
· INJEX Pharma
· European Pharma Group
· Crossject
· Portal Instruments
· Valeritas Inc,
· Bioject Medical Technologies Inc

Product Portfolio:

Stratis IM/SC: The Stratis Needle-Free Injection System delivers precise and consistent 0.5 ml intramuscular and subcutaneous injections, enabling patients to achieve optimal results with their medications.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/europe-needle-free-injection-market

Related Reports:

Needle Free Injection Market: https://www.datamintelligence.com/research-report/needle-free-injection-market

Neurogenic Bladder Infections Market: https://www.datamintelligence.com/research-report/neurogenic-bladder-infections-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.